Omega Healthcare Investors (OHI) Financials

Omega Healthcare Investors’ (NYSE: OHI) second-quarter 2026 results showed a sharp improvement in reported earnings, although much of the increase came from investment gains rather than recurring operations. Total revenue rose to $526.6 million from $252.5 million in Q2 2025, while net income attributable to common shareholders increased to $362.8 million from $136.6 million. Diluted earnings per share climbed to $1.19 from $0.46. The comparison is affected by unusually large net realized and unrealized investment gains of $246.5 million in Q2 2026.

The company’s recurring financial profile also improved in several areas. Net interest expense narrowed to $1.4 million from $9.9 million a year earlier, as interest income increased and interest expense declined. Total debt fell to approximately $4.02 billion at June 30, 2026, compared with roughly $5.00 billion at June 30, 2025. However, operating cash flow declined modestly year over year to $217.7 million from $239.3 million, and the quarter’s investment gains were a major contributor to reported profitability.

Over the broader period provided, OHI’s asset base expanded from $9.29 billion in Q1 2023 to $10.01 billion in Q2 2026, while net premises and equipment increased from $6.44 billion to $6.47 billion. Common equity also increased, but retained earnings remained negative at approximately $3.51 billion. Investors should also note that several historical figures were restated, and the supplied data does not include funds from operations or adjusted funds from operations, which are important measures for evaluating a healthcare REIT.

• Reported earnings accelerated: Q2 2026 net income attributable to common shareholders increased approximately 165% year over year, and diluted EPS rose from $0.46 to $1.19.
• Investment portfolio gains boosted results: OHI recorded $246.5 million of net realized and unrealized investment gains in Q2 2026, compared with $22.9 million in Q2 2025.
• Interest burden improved: Net interest expense narrowed from $9.9 million to $1.4 million year over year, helped by higher interest income and lower interest expense.
• Debt declined materially: Total short- and long-term debt fell to about $4.02 billion in Q2 2026 from approximately $5.00 billion in Q2 2025, improving balance-sheet flexibility.
• Operating cash flow remained strong: OHI generated $217.7 million of operating cash flow in Q2 2026, providing substantial funding for dividends and other capital needs.
• Asset growth continued over the multi-year period: Total assets increased from $9.29 billion in Q1 2023 to $10.01 billion in Q2 2026, while net property and equipment generally remained above $6 billion.
• Liquidity composition changed significantly: Q2 2026 cash and due from banks was only $39.0 million, but restricted cash and trading account securities totaled approximately $646.5 million.
• Equity issuance supported financing: OHI issued $61.4 million of common equity in Q2 2026 and $104.9 million in Q1, contributing to higher common shares outstanding.
• Cash flow weakened year over year: Operating cash flow declined from $239.3 million in Q2 2025 to $217.7 million in Q2 2026 despite the substantial increase in reported net income.
• Reported earnings remain dependent on volatile items: Large investment gains and other non-interest income accounted for much of Q2 2026’s earnings surge, while retained earnings remained negative at approximately $3.51 billion.